{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["SAR", "anticancer activity", "anticancer potency", "anticancer selectivity", "benzofuran", "hybrid benzofurans"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35565325", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "04", "Day": "28"}], "Language": ["eng"], "ELocationID": ["2196", "10.3390/cancers14092196"], "Journal": {"ISSN": "2072-6694", "JournalIssue": {"Volume": "14", "Issue": "9", "PubDate": {"Year": "2022", "Month": "Apr", "Day": "28"}}, "Title": "Cancers", "ISOAbbreviation": "Cancers (Basel)"}, "ArticleTitle": "Structure-Activity Relationship of Benzofuran Derivatives with Potential Anticancer Activity.", "Abstract": {"AbstractText": ["Benzofuran is a heterocyclic compound found naturally in plants and it can also be obtained through synthetic reactions. Multiple physicochemical characteristics and versatile features distinguish benzofuran, and its chemical structure is composed of fused benzene and furan rings. Benzofuran derivatives are essential compounds that hold vital biological activities to design novel therapies with enhanced efficacy compared to conventional treatments. Therefore, medicinal chemists used its core to synthesize new derivatives that can be applied to a variety of disorders. Benzofuran exhibited potential effectiveness in chronic diseases such as hypertension, neurodegenerative and oxidative conditions, and dyslipidemia. In acute infections, benzofuran revealed anti-infective properties against microorganisms like viruses, bacteria, and parasites. In recent years, the complex nature and the number of acquired or resistant cancer cases have been largely increasing. Benzofuran derivatives revealed potential anticancer activity with lower incidence or severity of adverse events normally encountered during chemotherapeutic treatments. This review discusses the structure-activity relationship (SAR) of several benzofuran derivatives in order to elucidate the possible substitution alternatives and structural requirements for a highly potent and selective anticancer activity."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Epidemiology and Population Health, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi P.O. Box 127788, United Arab Emirates."}], "LastName": "Farhat", "ForeName": "Joviana", "Initials": "J"}, {"Identifier": ["0000-0001-9307-3644"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Al Ain University, Abu Dhabi P.O. Box 64141, United Arab Emirates."}, {"Identifier": [], "Affiliation": "Health and Biomedical Research Center, Al Ain University, Abu Dhabi P.O. Box 64141, United Arab Emirates."}], "LastName": "Alzyoud", "ForeName": "Lara", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Leibniz-Institut F\u00fcr Analytische Wissenschaften-ISAS e.V., 44139 Dortmund, Germany."}, {"Identifier": [], "Affiliation": "Institute of Pathology and Medical Research Center (ZMF), University Medical Center Mannheim, Heid Elberg University, 68167 Mannheim, Germany."}, {"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Pharmacy, AlZaytoonah University of Jordan, P.O. Box 130, Amman 11733, Jordan."}], "LastName": "Alwahsh", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": ["0000-0002-7804-8050"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Epidemiology and Population Health, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi P.O. Box 127788, United Arab Emirates."}, {"Identifier": [], "Affiliation": "KU Research and Data Intelligence Support Center (RDISC) AW 8474000331, Khalifa University of Science and Technology, Abu Dhabi P.O. Box 127788, United Arab Emirates."}], "LastName": "Al-Omari", "ForeName": "Basem", "Initials": "B"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Cancers (Basel)", "NlmUniqueID": "101526829", "ISSNLinking": "2072-6694"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Chand K., Hiremathad A., Singh M., Santos M.A., Keri R.S. A Review on Antioxidant Potential of Bioactive Heterocycle Benzofuran: Natural and Synthetic Derivatives. Pharmacol. Rep. 2017;69:281\u2013295. doi: 10.1016/j.pharep.2016.11.007.", "ArticleIdList": ["10.1016/j.pharep.2016.11.007", "28171830"]}, {"Citation": "Radadiya A., Shah A. Bioactive Benzofuran Derivatives: An Insight on Lead Developments, Radioligands and Advances of the Last Decade. Eur. J. Med. Chem. 2015;97:356\u2013376. doi: 10.1016/j.ejmech.2015.01.021.", "ArticleIdList": ["10.1016/j.ejmech.2015.01.021", "25703339"]}, {"Citation": "Proksch P., Rodriguez E. Chromenes and Benzofurans of the Asteraceae, Their Chemistry and Biological Significance. Phytochemistry. 1983;22:2335\u20132348. doi: 10.1016/0031-9422(83)80118-6.", "ArticleIdList": ["10.1016/0031-9422(83)80118-6"]}, {"Citation": "Heravi M.M., Zadsirjan V., Hamidi H., Tabar Amiri P.H. Total Synthesis of Natural Products Containing Benzofuran Rings. RSC Adv. 2017;7:24470\u201324521. doi: 10.1039/C7RA03551A.", "ArticleIdList": ["10.1039/C7RA03551A"]}, {"Citation": "Collin G., H\u00f6ke H. Ullmann\u2019s Encyclopedia of Industrial Chemistry. Wiley; Hoboken, NJ, USA: 2007. Benzofurans.", "ArticleIdList": ["10.1002/14356007.L03_L01"]}, {"Citation": "Jung J.W., Park J.H., Seo K.H., Oh E.J., Lee D.Y., Lim D.W., Han D., Song M.C., Baek N.I. New Hydroxy Fatty Acid from the Root Bark of Morus alba L. J. Korean Soc. Appl. Biol. Chem. 2015;58:541\u2013543. doi: 10.1007/s13765-015-0071-5.", "ArticleIdList": ["10.1007/s13765-015-0071-5"]}, {"Citation": "Modell A.E., Blosser S.L., Arora P.S. Systematic Targeting of Protein\u2013Protein Interactions. Trends Pharmacol. Sci. 2016;37:702\u2013713. doi: 10.1016/j.tips.2016.05.008.", "ArticleIdList": ["10.1016/j.tips.2016.05.008", "PMC4961577", "27267699"]}, {"Citation": "Xu Z., Zhao S., Lv Z., Feng L., Wang Y., Zhang F., Bai L., Deng J. Benzofuran Derivatives and Their Anti-Tubercular, Anti-Bacterial Activities. Eur. J. Med. Chem. 2019;162:266\u2013276. doi: 10.1016/j.ejmech.2018.11.025.", "ArticleIdList": ["10.1016/j.ejmech.2018.11.025", "30448416"]}, {"Citation": "Nevagi R.J., Dighe S.N., Dighe S.N. Biological and Medicinal Significance of Benzofuran. Eur. J. Med. Chem. 2015;97:561\u2013581. doi: 10.1016/j.ejmech.2014.10.085.", "ArticleIdList": ["10.1016/j.ejmech.2014.10.085", "26015069"]}, {"Citation": "Hiremathad A., Patil M.R., Chethana K.R., Chand K., Santos M.A., Keri R.S. Benzofuran: An Emerging Scaffold for Antimicrobial Agents. RSC Adv. 2015;5:96809\u201396828. doi: 10.1039/C5RA20658H.", "ArticleIdList": ["10.1039/C5RA20658H"]}, {"Citation": "Zhong M., Peng E., Huang N., Huang Q., Huq A., Lau M., Colonno R., Li L. Discovery of Novel Potent HCV NS5B Polymerase Non-Nucleoside Inhibitors Bearing a Fused Benzofuran Scaffold. Bioorg. Med. Chem. Lett. 2018;28:963\u2013968. doi: 10.1016/j.bmcl.2018.01.029.", "ArticleIdList": ["10.1016/j.bmcl.2018.01.029", "29422387"]}, {"Citation": "Goyal D., Kaur A., Goyal B. Benzofuran and Indole: Promising Scaffolds for Drug Development in Alzheimer\u2019s Disease. ChemMedChem. 2018;13:1275\u20131299. doi: 10.1002/cmdc.201800156.", "ArticleIdList": ["10.1002/cmdc.201800156", "29742314"]}, {"Citation": "Subair T.I., Soremekun O.S., Olotu F.A., Soliman M.E.S. Therapeutic Path to Double Knockout: Investigating the Selective Dual-Inhibitory Mechanisms of Adenosine Receptors A1 and A2 by a Novel Methoxy-Substituted Benzofuran Derivative in the Treatment of Parkinson\u2019s Disease. Cell Biochem. Biophys. 2021;79:25\u201336. doi: 10.1007/s12013-020-00957-8.", "ArticleIdList": ["10.1007/s12013-020-00957-8", "33222095"]}, {"Citation": "Wakabayashi T., Tokunaga N., Tokumaru K., Ohra T., Koyama N., Hayashi S., Yamada R., Shirasaki M., Inui Y., Tsukamoto T. Discovery of Benzofuran Derivatives That Collaborate with Insulin-Like Growth Factor 1 (IGF-1) to Promote Neuroprotection. J. Med. Chem. 2016;59:5109\u20135114. doi: 10.1021/acs.jmedchem.6b00191.", "ArticleIdList": ["10.1021/acs.jmedchem.6b00191", "27163512"]}, {"Citation": "Sashidhara K.V., Modukuri R.K., Sonkar R., Rao K.B., Bhatia G. Hybrid Benzofuran-Bisindole Derivatives: New Prototypes with Promising Anti-Hyperlipidemic Activities. Eur. J. Med. Chem. 2013;68:38\u201346. doi: 10.1016/j.ejmech.2013.07.009.", "ArticleIdList": ["10.1016/j.ejmech.2013.07.009", "23954239"]}, {"Citation": "Khalifa N.M., Srour A.M., El-Karim S.S.A., Saleh D.O., Al-Omar M.A. Synthesis and 2D-QSAR Study of Active Benzofuran-Based Vasodilators. Molecules. 2017;22:1820. doi: 10.3390/molecules22111820.", "ArticleIdList": ["10.3390/molecules22111820", "PMC6150240", "29072621"]}, {"Citation": "Dawood K.M. An Update on Benzofuran Inhibitors: A Patent Review. Expert Opin. Ther. Pat. 2019;29:841\u2013870. doi: 10.1080/13543776.2019.1673727.", "ArticleIdList": ["10.1080/13543776.2019.1673727", "31560232"]}, {"Citation": "Miao Y.H., Hu Y.H., Yang J., Liu T., Sun J., Wang X.J. Natural Source, Bioactivity and Synthesis of Benzofuran Derivatives. RSC Adv. 2019;9:27510\u201327540. doi: 10.1039/C9RA04917G.", "ArticleIdList": ["10.1039/C9RA04917G", "PMC9070854", "35529241"]}, {"Citation": "Pucci C., Martinelli C., Ciofani G. Innovative Approaches for Cancer Treatment: Current Perspectives and New Challenges. Ecancermedicalscience. 2019;13:961. doi: 10.3332/ecancer.2019.961.", "ArticleIdList": ["10.3332/ecancer.2019.961", "PMC6753017", "31537986"]}, {"Citation": "Ferlay J., Ervik M., Lam F., Colombet M., Mery L., Pi\u00f1eros M., Znaor A., Soerjomataram I., Bray F. Global Cancer Observatory: Cancer Today.  [(accessed on 11 December 2021)].  Available online:  https://gco.iarc.fr/today."}, {"Citation": "Martins P., Jesus J., Santos S., Raposo L.R., Roma-Rodrigues C., Baptista P.V., Fernandes A.R. Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine\u2019s Tool Box. Molecules. 2015;20:16852\u201316891. doi: 10.3390/molecules200916852.", "ArticleIdList": ["10.3390/molecules200916852", "PMC6331900", "26389876"]}, {"Citation": "Khodarahmi G., Asadi P., Hassanzadeh F., Khodarahmi E. Benzofuran as a Promising Scaffold for the Synthesis of Antimicrobial and Antibreast Cancer Agents: A Review. J. Res. Med. Sci. 2015;20:1094\u20131104. doi: 10.4103/1735-1995.172835.", "ArticleIdList": ["10.4103/1735-1995.172835", "PMC4755098", "26941815"]}, {"Citation": "Gao H., Zhang X., Pu X.J., Zheng X., Liu B., Rao G.X., Wan C.P., Mao Z.W. 2-Benzoylbenzofuran Derivatives Possessing Piperazine Linker as Anticancer Agents. Bioorg. Med. Chem. Lett. 2019;29:806\u2013810. doi: 10.1016/j.bmcl.2019.01.025.", "ArticleIdList": ["10.1016/j.bmcl.2019.01.025", "30709651"]}, {"Citation": "Negalurmath V.S., Boda S.K., Kotresh O., Anantha Lakshmi P.V., Basanagouda M. Benzofuran-Oxadiazole Hybrids: Design, Synthesis, Antitubercular Activity and Molecular Docking Studies. Chem. Data Collect. 2019;19:100178. doi: 10.1016/j.cdc.2019.100178.", "ArticleIdList": ["10.1016/j.cdc.2019.100178"]}, {"Citation": "Li W., Yang Z.H., Hu A.X., Yan X.W., Ding N., Ye J. Design, Synthesis, and Antitumor Activity of (E,Z)-1-(Dihydrobenzofuran-5-Yl)-3-Phenyl-2-(1,2,4-Triazol-1-Yl)-2-Propen-1-Ones. Chem. Biol. Drug Des. 2015;86:1339\u20131350. doi: 10.1111/cbdd.12601.", "ArticleIdList": ["10.1111/cbdd.12601", "26041467"]}, {"Citation": "Jin L.P., Xie Q., Huang E.F., Wang L., Zhang B.Q., Hu J.S., Wan D.C.C., Jin Z., Hu C. Design, Synthesis, and Biological Activity of a Novel Series of Benzofuran Derivatives against Oestrogen Receptor-Dependent Breast Cancer Cell Lines. Bioorg. Chem. 2020;95:103566. doi: 10.1016/j.bioorg.2020.103566.", "ArticleIdList": ["10.1016/j.bioorg.2020.103566", "31935604"]}, {"Citation": "Lu B., Shen X., Zhang L., Liu D., Zhang C., Cao J., Shen R., Zhang J., Wang D., Wan H., et al. Discovery of EBI-2511: A Highly Potent and Orally Active EZH2 Inhibitor for the Treatment of Non-Hodgkin\u2019s Lymphoma. ACS Med. Chem. Lett. 2018;9:98\u2013102. doi: 10.1021/acsmedchemlett.7b00437.", "ArticleIdList": ["10.1021/acsmedchemlett.7b00437", "PMC5807876", "29456795"]}, {"Citation": "Krawiecka M., Kuran B., Kossakowski J., Cieslak M., Kazmierczak- Baranska J., Krolewska K., Nawrot B. Synthesis and Cytotoxic Properties of Halogen and Aryl-/Heteroarylpiperazinyl Derivatives of Benzofurans. Anticancer Agents Med. Chem. 2014;15:115\u2013121. doi: 10.2174/187152061501141204124709.", "ArticleIdList": ["10.2174/187152061501141204124709", "25482722"]}, {"Citation": "Amin K.M., Syam Y.M., Anwar M.M., Ali H.I., Abdel-Ghani T.M., Serry A.M. Synthesis and Molecular Docking Study of New Benzofuran and Furo[3,2-g]Chromone-Based Cytotoxic Agents against Breast Cancer and P38\u03b1 MAP Kinase Inhibitors. Bioorg. Chem. 2018;76:487\u2013500. doi: 10.1016/j.bioorg.2017.12.029.", "ArticleIdList": ["10.1016/j.bioorg.2017.12.029", "29310080"]}, {"Citation": "Kang T.S., Wang W., Zhong H.J., Dong Z.Z., Huang Q., Mok S.W.F., Leung C.H., Wong V.K.W., Ma D.L. An Anti-Prostate Cancer Benzofuran-Conjugated Iridium(III) Complex as a Dual Inhibitor of STAT3 and NF-\u039aB. Cancer Lett. 2017;396:76\u201384. doi: 10.1016/j.canlet.2017.03.016.", "ArticleIdList": ["10.1016/j.canlet.2017.03.016", "28323031"]}, {"Citation": "Ford M.C., Ho P.S. Computational Tools To Model Halogen Bonds in Medicinal Chemistry. J. Med. Chem. 2015;59:1655\u20131670. doi: 10.1021/acs.jmedchem.5b00997.", "ArticleIdList": ["10.1021/acs.jmedchem.5b00997", "26465079"]}, {"Citation": "Wilcken R., Zimmermann M.O., Lange A., Joerger A.C., Boeckler F.M. Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology. J. Med. Chem. 2013;56:1363\u20131388. doi: 10.1021/jm3012068.", "ArticleIdList": ["10.1021/jm3012068", "23145854"]}, {"Citation": "Abdelfatah S., Berg A., Huang Q., Yang L.J., Hamdoun S., Klinger A., Greten H.J., Fleischer E., Berg T., Wong V.K.W., et al. MCC1019, a Selective Inhibitor of the Polo-Box Domain of Polo-like Kinase 1 as Novel, Potent Anticancer Candidate. Acta Pharm. Sin. B. 2019;9:1021\u20131034. doi: 10.1016/j.apsb.2019.02.001.", "ArticleIdList": ["10.1016/j.apsb.2019.02.001", "PMC6804483", "31649851"]}, {"Citation": "Napi\u00f3rkowska M., Cie\u015blak M., Ka\u017amierczak-Bara\u0144ska J., Kr\u00f3lewska-Goli\u0144ska K., Nawrot B. Synthesis of New Derivatives of Benzofuran as Potential Anticancer Agents. Molecules. 2019;24:1529. doi: 10.3390/molecules24081529.", "ArticleIdList": ["10.3390/molecules24081529", "PMC6514909", "31003438"]}, {"Citation": "Othman D.I., Abdelal A.M.M., El-Sayed M.A., El Bialy S.A.A. Novel Benzofuran Derivatives: Synthesis and Antitumor Activity. Heterocycl. Commun. 2013;19:29\u201335. doi: 10.1515/hc-2012-0119.", "ArticleIdList": ["10.1515/hc-2012-0119"]}, {"Citation": "Wan W.C., Chen W., Liu L.X., Li Y., Yang L.J., Deng X.Y., Zhang H.B., Yang X.D. Synthesis and Cytotoxic Activity of Novel Hybrid Compounds between 2-Alkylbenzofuran and Imidazole. Med. Chem. Res. 2014;23:1599\u20131611. doi: 10.1007/s00044-013-0760-8.", "ArticleIdList": ["10.1007/s00044-013-0760-8"]}, {"Citation": "Yang X.D., Wan W.C., Deng X.Y., Li Y., Yang L.J., Li L., Zhang H.B. Design, Synthesis and Cytotoxic Activities of Novel Hybrid Compounds between 2-Phenylbenzofuran and Imidazole. Bioorg. Med. Chem. Lett. 2012;22:2726\u20132729. doi: 10.1016/j.bmcl.2012.02.094.", "ArticleIdList": ["10.1016/j.bmcl.2012.02.094", "22440627"]}, {"Citation": "Chen Y., Law P.-Y., Loh H. Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy. Curr. Med. Chem. Agents. 2005;5:575\u2013589. doi: 10.2174/156801105774574649.", "ArticleIdList": ["10.2174/156801105774574649", "16305480"]}, {"Citation": "Choi M., Jo H., Park H.J., Sateesh Kumar A., Lee J., Yun J., Kim Y., Han S.B., Jung J.K., Cho J., et al. Design, Synthesis, and Biological Evaluation of Benzofuran- and 2,3-Dihydrobenzofuran-2-Carboxylic Acid N-(Substituted)Phenylamide Derivatives as Anticancer Agents and Inhibitors of NF-\u039aB. Bioorg. Med. Chem. Lett. 2015;25:2545\u20132549. doi: 10.1016/j.bmcl.2015.04.050.", "ArticleIdList": ["10.1016/j.bmcl.2015.04.050", "25953156"]}, {"Citation": "Mao Z.W., Zheng X., Lin Y.P., Hu C.Y., Wang X.L., Wan C.P., Rao G.X. Design, Synthesis and Anticancer Activity of Novel Hybrid Compounds between Benzofuran and N-Aryl Piperazine. Bioorg. Med. Chem. Lett. 2016;26:3421\u20133424. doi: 10.1016/j.bmcl.2016.06.055.", "ArticleIdList": ["10.1016/j.bmcl.2016.06.055", "27371110"]}, {"Citation": "Wang F., Feng K.R., Zhao J.Y., Zhang J.W., Shi X.W., Zhou J., Gao D., Lin G.Q., Tian P. Identification of Novel STAT3 Inhibitors Bearing 2-Acetyl-7-Phenylamino Benzofuran Scaffold for Antitumour Study. Bioorg. Med. Chem. 2020;28:115822. doi: 10.1016/j.bmc.2020.115822.", "ArticleIdList": ["10.1016/j.bmc.2020.115822", "33126089"]}, {"Citation": "Youssif B.G.M., Mohamed A.M., Osman E.E.A., Abou-Ghadir O.F., Elnaggar D.H., Abdelrahman M.H., Treamblu L., Gomaa H.A.M. 5-Chlorobenzofuran-2-Carboxamides: From Allosteric CB1 Modulators to Potential Apoptotic Antitumor Agents. Eur. J. Med. Chem. 2019;177:1\u201311. doi: 10.1016/j.ejmech.2019.05.040.", "ArticleIdList": ["10.1016/j.ejmech.2019.05.040", "31128433"]}, {"Citation": "Riss T.L., Moravec R.A., Niles A.L., Duellman S., Benink H.A., Worzella T.J., Minor L. Cell Viability Assays. Eli Lilly & Company and the National Center for Advancing Translational Sciences; Bethesda, MD, USA: 2004.", "ArticleIdList": ["23805433"]}, {"Citation": "Abdelhafez O.M., Amin K.M., Ali H.I., Abdalla M.M., Ahmed E.Y. Design, Synthesis and Anticancer Activity of Benzofuran Derivatives Targeting VEGFR-2 Tyrosine Kinase. RSC Adv. 2014;4:11569\u201311579. doi: 10.1039/c4ra00943f.", "ArticleIdList": ["10.1039/c4ra00943f"]}, {"Citation": "Adem F.A., Kuete V., Mbaveng A.T., Heydenreich M., Ndakala A., Irungu B., Efferth T., Yenesew A. Cytotoxic Benzylbenzofuran Derivatives from Dorstenia Kameruniana. Fitoterapia. 2018;128:26\u201330. doi: 10.1016/j.fitote.2018.04.019.", "ArticleIdList": ["10.1016/j.fitote.2018.04.019", "29715541"]}, {"Citation": "Co\u015fkun D., Tekin S., Sandal S., Co\u015fkun M.F. Synthesis, Characterization, and Anticancer Activity of New Benzofuran Substituted Chalcones. J. Chem. 2016;2016:7678486. doi: 10.1155/2016/7678486.", "ArticleIdList": ["10.1155/2016/7678486"]}, {"Citation": "Asadi P., Khodarahmi G., Jahanian-Najafabadi A., Saghaie L., Hassanzadeh F. Biologically Active Heterocyclic Hybrids Based on Quinazolinone, Benzofuran and Imidazolium Moieties: Synthesis, Characterization, Cytotoxic and Antibacterial Evaluation. Chem. Biodivers. 2017;14 doi: 10.1002/cbdv.201600411.", "ArticleIdList": ["10.1002/cbdv.201600411", "28002645"]}, {"Citation": "Etebari M., Khodarahmi G.A., Jafarian-Dehkordi A., Nokhodian Z. Genotoxic Effects of Some L-[(Benzofuran-2-Yl)-Phenylmethyl]-Imidazoles on MCF-7 Cell Line. Res. Pharm. Sci. 2012;7:189\u2013195.", "ArticleIdList": ["PMC3501928", "23181097"]}, {"Citation": "Irfan A., Faiz S., Rasul A., Zafar R., Zahoor A.F., Kotwica-Mojzych K., Mojzych M. Exploring the Synergistic Anticancer Potential of Benzofuran\u2013Oxadiazoles and Triazoles: Improved Ultrasound-and Microwave-Assisted Synthesis, Molecular Docking, Hemolytic, Thrombolytic and Anticancer Evaluation of Furan-Based Molecules. Molecules. 2022;27:1023. doi: 10.3390/molecules27031023.", "ArticleIdList": ["10.3390/molecules27031023", "PMC8838991", "35164286"]}, {"Citation": "Jia Y., Li M., Cao Y., Feng W., Li X., Xue W., Shi H. Discovery of a Novel Benzenesulfonamide Analogue That Inhibits Proliferation and Metastasis against Ovarian Cancer OVCAR-8 Cells. Drug Des. Devel. Ther. 2020;14:207\u2013216. doi: 10.2147/DDDT.S225201.", "ArticleIdList": ["10.2147/DDDT.S225201", "PMC6974418", "32021105"]}, {"Citation": "Yang Y.R., Wei J.L., Mo X.F., Yuan Z.W., Wang J.L., Zhang C., Xie Y.Y., You Q.D., Sun H.P. Discovery and Optimization of New Benzofuran Derivatives against P53-Independent Malignant Cancer Cells through Inhibition of HIF-1 Pathway. Bioorg. Med. Chem. Lett. 2016;26:2713\u20132718. doi: 10.1016/j.bmcl.2016.03.112.", "ArticleIdList": ["10.1016/j.bmcl.2016.03.112", "27101893"]}, {"Citation": "Semenza G.L. Defining the Role of Hypoxia-Inducible Factor 1 in Cancer Biology and Therapeutics. Oncogene. 2010;29:625\u2013634. doi: 10.1038/onc.2009.441.", "ArticleIdList": ["10.1038/onc.2009.441", "PMC2969168", "19946328"]}, {"Citation": "Nakamura H., Yasui Y., Maruyama M., Minegishi H., Ban H.S., Sato S. Development of Hypoxia-Inducible Factor (HIF)-1\u03b1 Inhibitors: Effect of Ortho-Carborane Substituents on HIF Transcriptional Activity under Hypoxia. Bioorg. Med. Chem. Lett. 2013;23:806\u2013810. doi: 10.1016/j.bmcl.2012.11.081.", "ArticleIdList": ["10.1016/j.bmcl.2012.11.081", "23267767"]}, {"Citation": "Mahmood N., Mihalcioiu C., Rabbani S.A. Multifaceted Role of the Urokinase-Type Plasminogen Activator (UPA) and Its Receptor (UPAR): Diagnostic, Prognostic, and Therapeutic Applications. Front. Oncol. 2018;8:24. doi: 10.3389/fonc.2018.00024.", "ArticleIdList": ["10.3389/fonc.2018.00024", "PMC5816037", "29484286"]}, {"Citation": "Ulisse S., Baldini E., Sorrenti S., D\u2019Armiento M. The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy. Curr. Cancer Drug Targets. 2009;9:32\u201371. doi: 10.2174/156800909787314002.", "ArticleIdList": ["10.2174/156800909787314002", "19200050"]}, {"Citation": "Croucher D.R., Saunders D.N., Lobov S., Ranson M. Revisiting the Biological Roles of PAI2 (SERPINB2) in Cancer. Nat. Rev. Cancer. 2008;8:535\u2013545. doi: 10.1038/nrc2400.", "ArticleIdList": ["10.1038/nrc2400", "18548086"]}, {"Citation": "Matthews H., Ranson M., Tyndall J.D.A., Kelso M.J. Synthesis and Preliminary Evaluation of Amiloride Analogs as Inhibitors of the Urokinase-Type Plasminogen Activator (UPA) Bioorg. Med. Chem. Lett. 2011;21:6760\u20136766. doi: 10.1016/j.bmcl.2011.09.044.", "ArticleIdList": ["10.1016/j.bmcl.2011.09.044", "21978672"]}, {"Citation": "Song C.W., Lyons J.C., Makepeace C.M., Griffin R.J., Cragoe E.J. Effect\u2019s of Hma, an Analog of Amiloride, on the Thermosensitivity of Tumors in Vivo. Int. J. Radiat. Oncol. Biol. Phys. 1994;30:133\u2013139. doi: 10.1016/0360-3016(94)90528-2.", "ArticleIdList": ["10.1016/0360-3016(94)90528-2", "8083106"]}, {"Citation": "Luo J., Tannock I.F. Inhibition of the Regulation of Intracellular PH: Potential of 5-(N,N-Hexamethylene) Amiloride in Tumour-Selective Therapy. Br. J. Cancer. 1994;70:617\u2013624. doi: 10.1038/bjc.1994.360.", "ArticleIdList": ["10.1038/bjc.1994.360", "PMC2033413", "7917906"]}, {"Citation": "Chemler S.R., Trauner D., Danishefsky S.J. The B -Alkyl Suzuki-Miyaura Cross-Coupling Reaction: A Versatile C-C Bond-Forming Tool REVIEWS The B -Alkyl Suzuki-Miyaura Cross-Coupling Reaction: Development, Mechanistic Study, and Applications in Natural Product Synthesis. Angew. Chem. Int. Ed. 2001;40:4544\u20134568. doi: 10.1002/1521-3773(20011217)40:24<4544::AID-ANIE4544>3.0.CO;2-N.", "ArticleIdList": ["10.1002/1521-3773(20011217)40:24<4544::AID-ANIE4544>3.0.CO;2-N", "12404358"]}, {"Citation": "Buckley B.J., Aboelela A., Minaei E., Jiang L.X., Xu Z., Ali U., Fildes K., Cheung C.Y., Cook S.M., Johnson D.C., et al. 6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer. J. Med. Chem. 2018;61:8299\u20138320. doi: 10.1021/acs.jmedchem.8b00838.", "ArticleIdList": ["10.1021/acs.jmedchem.8b00838", "PMC6290913", "30130401"]}, {"Citation": "Gao Y., Ma C., Feng X., Liu Y., Haimiti X. BF12, a Novel Benzofuran, Exhibits Antitumor Activity by Inhibiting Microtubules and the PI3K/Akt/MTOR Signaling Pathway in Human Cervical Cancer Cells. Chem. Biodivers. 2020;17 doi: 10.1002/cbdv.201900622.", "ArticleIdList": ["10.1002/cbdv.201900622", "31951313"]}, {"Citation": "Soleimani A., Asadi J., Rostami-Charati F., Gharaei R. High Cytotoxicity and Apoptotic Effects of Natural Bioactive Benzofuran Derivative on the MCF-7 Breast Cancer Cell Line. Comb. Chem. High Throughput Screen. 2015;18:505\u2013513. doi: 10.2174/1386207318666150430114815.", "ArticleIdList": ["10.2174/1386207318666150430114815", "25924658"]}, {"Citation": "Mishra S. Quinazolinone and Quinazoline Derivatives: Synthesis and Biological Application. Intechopen; London, UK: 2019.", "ArticleIdList": ["10.5772/INTECHOPEN.89203"]}, {"Citation": "Radwan A.A., Alanazi F.K. Biological Activity of Quinazolinones. Intechopen; London, UK: 2020.", "ArticleIdList": ["10.5772/intechopen.90621"]}, {"Citation": "Jafari E., Khajouei M.R., Hassanzadeh F., Hakimelahi G.H., Khodarahmi G.A. Quinazolinone and Quinazoline Derivatives: Recent Structures with Potent Antimicrobial and Cytotoxic Activities. Res. Pharm. Sci. 2016;11:1\u201314.", "ArticleIdList": ["PMC4794932", "27051427"]}, {"Citation": "Kuttan R., Bhanumathy P., Nirmala K., George M.C. Potential Anticancer Activity of Turmeric (Curcuma Longa) Cancer Lett. 1985;29:197\u2013202. doi: 10.1016/0304-3835(85)90159-4.", "ArticleIdList": ["10.1016/0304-3835(85)90159-4", "4075289"]}, {"Citation": "Kumar B.R.P., Sharma G.K., Srinath S., Noor M., Suresh B., Srinivasa B.R. Microwave-Assisted, Solvent-Free, Parallel Syntheses and Elucidation of Reaction Mechanism for the Formation of Some Novel Tetraaryl Imidazoles of Biological Interest. J. Heterocycl. Chem. 2009;46:278\u2013284. doi: 10.1002/jhet.68.", "ArticleIdList": ["10.1002/jhet.68"]}, {"Citation": "Sharma G.K., Pathak D. Microwave-Assisted, Solvent-Free and Parallel Synthesis of Some Novel Substituted Imidazoles of Biological Interest. Chem. Pharm. Bull. 2010;58:375\u2013380. doi: 10.1248/cpb.58.375.", "ArticleIdList": ["10.1248/cpb.58.375", "20190444"]}, {"Citation": "Shankar B., Jalapathi P., Saikrishna B., Perugu S., Manga V. Synthesis, Anti-Microbial Activity, Cytotoxicity of Some Novel Substituted (5-(3-(1H-Benzo[d]Imidazol-2-Yl)-4-Hydroxybenzyl)Benzofuran-2-Yl)(Phenyl)Methanone Analogs. Chem. Cent. J. 2018;12:1. doi: 10.1186/s13065-017-0364-3.", "ArticleIdList": ["10.1186/s13065-017-0364-3", "PMC5760494", "29318401"]}, {"Citation": "Kumar Saxena R., Kumar P., Varshney S. Synthesis and Biological Evaluation of Newer Benzofuran Derivatives as Potential Anticancer and Antithelmintic Agents. World J. Pharm. Res. 2015;3:821."}, {"Citation": "Khanam H., Shamsuzzaman Bioactive Benzofuran Derivatives: A Review. Eur. J. Med. Chem. 2015;97:483\u2013504. doi: 10.1016/j.ejmech.2014.11.039.", "ArticleIdList": ["10.1016/j.ejmech.2014.11.039", "25482554"]}, {"Citation": "Nam N.-H. Combretastatin A-4 Analogues as Antimitotic Antitumor Agents. Curr. Med. Chem. 2005;10:1697\u20131722. doi: 10.2174/0929867033457151.", "ArticleIdList": ["10.2174/0929867033457151", "12871118"]}, {"Citation": "Flynn B.L., Gill G.S., Grobelny D.W., Chaplin J.H., Paul D., Leske A.F., Lavranos T.C., Chalmers D.K., Charman S.A., Kostewicz E., et al. Discovery of 7-Hydroxy-6-Methoxy-2-Methyl-3-(3,4,5-Trimethoxybenzoyl)Benzo[ b ]Furan (BNC105), a Tubulin Polymerization Inhibitor with Potent Antiproliferative and Tumor Vascular Disrupting Properties. J. Med. Chem. 2011;54:6014\u20136027. doi: 10.1021/jm200454y.", "ArticleIdList": ["10.1021/jm200454y", "PMC3172808", "21774499"]}, {"Citation": "Vignot S., Faivre S., Aguirre D., Raymond E. MTOR-Targeted Therapy of Cancer with Rapamycin Derivatives. Ann. Oncol. 2005;16:525\u2013537. doi: 10.1093/annonc/mdi113.", "ArticleIdList": ["10.1093/annonc/mdi113", "15728109"]}, {"Citation": "Albert S., Serova M., Dreyer C., Sablin M.P., Faivre S., Raymond E. New Inhibitors of the Mammalian Target of Rapamycin Signaling Pathway for Cancer. Expert Opin. Investig. Drugs. 2010;19:919\u2013930. doi: 10.1517/13543784.2010.499121.", "ArticleIdList": ["10.1517/13543784.2010.499121", "20569080"]}, {"Citation": "Faivre S., Kroemer G., Raymond E. Current Development of MTOR Inhibitors as Anticancer Agents. Nat. Rev. Drug Discov. 2006;5:671\u2013688. doi: 10.1038/nrd2062.", "ArticleIdList": ["10.1038/nrd2062", "16883305"]}, {"Citation": "Salom\u00e9 C., Narbonne V., Ribeiro N., Thuaud F., Serova M., De Gramont A., Faivre S., Raymond E., D\u00e9saubry L. Benzofuran Derivatives as a Novel Class of Inhibitors of MTOR Signaling. Eur. J. Med. Chem. 2014;74:41\u201349. doi: 10.1016/j.ejmech.2013.12.020.", "ArticleIdList": ["10.1016/j.ejmech.2013.12.020", "24445311"]}, {"Citation": "Salom\u00e9 C., Ribeiro N., Chavagnan T., Thuaud F., Serova M., De Gramont A., Faivre S., Raymond E., D\u00e9saubry L. Benzofuran Derivatives as Anticancer Inhibitors of MTOR Signaling. Eur. J. Med. Chem. 2014;81:181\u2013191. doi: 10.1016/j.ejmech.2014.05.014.", "ArticleIdList": ["10.1016/j.ejmech.2014.05.014", "24836070"]}, {"Citation": "Garrido-Laguna I., Hidalgo M. Pancreatic Cancer: From State-of-the-Art Treatments to Promising Novel Therapies. Nat. Rev. Clin. Oncol. 2015;12:319\u2013334. doi: 10.1038/nrclinonc.2015.53.", "ArticleIdList": ["10.1038/nrclinonc.2015.53", "25824606"]}, {"Citation": "Spivak-Kroizman T.R., Hostetter G., Posner R., Aziz M., Hu C., Demeure M.J., Von Hoff D., Hingorani S.R., Palculict T.B., Izzo J., et al. Hypoxia Triggers Hedgehog-Mediated Tumor-Stromal Interactions in Pancreatic Cancer. Cancer Res. 2013;73:3235\u20133247. doi: 10.1158/0008-5472.CAN-11-1433.", "ArticleIdList": ["10.1158/0008-5472.CAN-11-1433", "PMC3782107", "23633488"]}, {"Citation": "Xu X.-L., Yang Y.-R., Mo X.-F., Wei J.-L., Zhang X.-J., You Q.-D. Design, Synthesis, and Evaluation of Benzofuran Derivatives as Novel Anti-Pancreatic Carcinoma Agents via Interfering the Hypoxia Environment by Targeting HIF-1\u03b1 Pathway. Eur. J. Med. Chem. 2017;137:45\u201362. doi: 10.1016/j.ejmech.2017.05.042.", "ArticleIdList": ["10.1016/j.ejmech.2017.05.042", "28554092"]}, {"Citation": "Naik R., Harmalkar D.S., Xu X., Jang K., Lee K. Bioactive Benzofuran Derivatives: Moracins A-Z in Medicinal Chemistry. Eur. J. Med. Chem. 2015;90:379\u2013393. doi: 10.1016/j.ejmech.2014.11.047.", "ArticleIdList": ["10.1016/j.ejmech.2014.11.047", "25461329"]}, {"Citation": "Ma Y., Zheng X., Gao H., Wan C., Rao G., Mao Z. Design, Synthesis, and Biological Evaluation of Novel Benzofuran Derivatives Bearing N-Aryl Piperazine Moiety. Molecules. 2016;21:1684. doi: 10.3390/molecules21121684.", "ArticleIdList": ["10.3390/molecules21121684", "PMC6274084", "27941680"]}, {"Citation": "Huang X.X., Zhou C.C., Li L.Z., Peng Y., Lou L.L., Liu S., Li D.M., Ikejima T., Song S.J. Cytotoxic and Antioxidant Dihydrobenzofuran Neolignans from the Seeds of Crataegus Pinnatifida. Fitoterapia. 2013;91:217\u2013223. doi: 10.1016/j.fitote.2013.09.011.", "ArticleIdList": ["10.1016/j.fitote.2013.09.011", "24060910"]}, {"Citation": "Chen W., Deng X.Y., Li Y., Yang L.J., Wan W.C., Wang X.Q., Zhang H.B., Yang X.D. Synthesis and Cytotoxic Activities of Novel Hybrid 2-Phenyl-3- Alkylbenzofuran and Imidazole/Triazole Compounds. Bioorg. Med. Chem. Lett. 2013;23:4297\u20134302. doi: 10.1016/j.bmcl.2013.06.001.", "ArticleIdList": ["10.1016/j.bmcl.2013.06.001", "23800685"]}, {"Citation": "Abd El-Karim S.S., Anwar M.M., Mohamed N.A., Nasr T., Elseginy S.A. Design, Synthesis, Biological Evaluation and Molecular Docking Studies of Novel Benzofuran-Pyrazole Derivatives as Anticancer Agents. Bioorg. Chem. 2015;63:1\u201312. doi: 10.1016/j.bioorg.2015.08.006.", "ArticleIdList": ["10.1016/j.bioorg.2015.08.006", "26368040"]}, {"Citation": "Murthy I.S., Sireesha R., Deepti K., Srinivasa Rao P., Ramesh Raju R. Design, Synthesis and Biological Evaluation of Sulphonamide Derivatives of Benzofuran-Imidazopyridines as Anticancer Agents. Chem. Data Collect. 2021;31:100608. doi: 10.1016/j.cdc.2020.100608.", "ArticleIdList": ["10.1016/j.cdc.2020.100608"]}, {"Citation": "Zwergel C., Valente S., Salvato A., Xu Z., Talhi O., Mai A., Silva A., Altucci L., Kirsch G. Novel Benzofuran-Chromone and -Coumarin Derivatives: Synthesis and Biological Activity in K562 Human Leukemia Cells. Med. Chem. Commun. 2013;4:1571\u20131579. doi: 10.1039/c3md00241a.", "ArticleIdList": ["10.1039/c3md00241a"]}, {"Citation": "Coskun D., Erkisa M., Ulukaya E., Coskun M.F., Ari F. Novel 1-(7-Ethoxy-1-Benzofuran-2-Yl) Substituted Chalcone Derivatives: Synthesis, Characterization and Anticancer Activity. Eur. J. Med. Chem. 2017;136:212\u2013222. doi: 10.1016/j.ejmech.2017.05.017.", "ArticleIdList": ["10.1016/j.ejmech.2017.05.017", "28494257"]}, {"Citation": "Al-Ghorbani M., Begum B.A., Mamatha S.V., Ara Khanum S. Piperazine and Morpholine: Synthetic Preview and Pharmaceutical Applications.  [(accessed on 17 November 2021)];J. Chem. Pharm. Res. 2015 7:281\u2013301. doi: 10.5958/0974-360X.2015.00100.6. Available online:  www.jocpr.com.", "ArticleIdList": ["10.5958/0974-360X.2015.00100.6"]}, {"Citation": "Rathi A.K., Syed R., Shin H.S., Patel R.V. Piperazine Derivatives for Therapeutic Use: A Patent Review (2010-Present) Expert Opin. Ther. Pat. 2016;26:777\u2013797. doi: 10.1080/13543776.2016.1189902.", "ArticleIdList": ["10.1080/13543776.2016.1189902", "27177234"]}, {"Citation": "Cuca L.E., David Coy E., Alarc\u00f3n M.A., Fern\u00e1ndez A., Aristiz\u00e1bal F.A. Cytotoxic Effect of Some Natural Compounds Isolated from Lauraceae Plants and Synthetic Derivatives. Biom\u00e9dica. 2011;31:335\u2013378. doi: 10.7705/biomedica.v31i3.347.", "ArticleIdList": ["10.7705/biomedica.v31i3.347", "22674310"]}, {"Citation": "Jiang Z.H., Liu Y.P., Huang Z.H., Wang T.T., Feng X.Y., Yue H., Guo W., Fu Y.H. Cytotoxic Dihydrobenzofuran Neolignans from Mappianthus Iodoies. Bioorg. Chem. 2017;75:260\u2013264. doi: 10.1016/j.bioorg.2017.10.003.", "ArticleIdList": ["10.1016/j.bioorg.2017.10.003", "29040842"]}, {"Citation": "Mansoor T.A., Borralho P.M., Luo X., Mulhovo S., Rodrigues C.M.P., Ferreira M.J.U. Apoptosis Inducing Activity of Benzophenanthridine-Type Alkaloids and 2-Arylbenzofuran Neolignans in HCT116 Colon Carcinoma Cells. Phytomedicine. 2013;20:923\u2013929. doi: 10.1016/j.phymed.2013.03.026.", "ArticleIdList": ["10.1016/j.phymed.2013.03.026", "23643093"]}, {"Citation": "Sivaraman A., Kim J.S., Harmalkar D.S., Min K.H., Park J.W., Choi Y., Kim K., Lee K. Synthesis and Cytotoxicity Studies of Bioactive Benzofurans from Lavandula Agustifolia and Modified Synthesis of Ailanthoidol, Homoegonol, and Egonol. J. Nat. Prod. 2020;83:3354\u20133362. doi: 10.1021/acs.jnatprod.0c00697.", "ArticleIdList": ["10.1021/acs.jnatprod.0c00697", "33073572"]}, {"Citation": "Zhou Z.B., Luo J.G., Pan K., Shan S.M., Zhang W., Kong L.Y. Bioactive Benzofuran Neolignans from Aristolochia Fordiana. Planta Med. 2013;79:1730\u20131735. doi: 10.1055/s-0033-1351100.", "ArticleIdList": ["10.1055/s-0033-1351100", "24288294"]}, {"Citation": "Z\u00e1le\u0161\u00e1k F., Bon D.J.Y.D., Posp\u00ed\u0161il J. Lignans and Neolignans: Plant Secondary Metabolites as a Reservoir of Biologically Active Substances. Pharmacol. Res. 2019;146:104284. doi: 10.1016/j.phrs.2019.104284.", "ArticleIdList": ["10.1016/j.phrs.2019.104284", "31136813"]}, {"Citation": "Sharma P., Larosa C., Antwi J., Govindarajan R., Werbovetz K.A. Imidazoles as Potential Anticancer Agents: An Update on Recent Studies. Molecules. 2021;26:4213. doi: 10.3390/molecules26144213.", "ArticleIdList": ["10.3390/molecules26144213", "PMC8307698", "34299488"]}, {"Citation": "Hranjec M., Sovi\u0107 I., Ratkaj I., Pavlovi\u0107 G., Ili\u0107 N., Valjalo L., Paveli\u0107 K., Kraljevi\u0107 Paveli\u0107 S., Karminski-Zamola G. Antiproliferative Potency of Novel Benzofuran-2-Carboxamides on Tumour Cell Lines: Cell Death Mechanisms and Determination of Crystal Structure. Eur. J. Med. Chem. 2013;59:111\u2013119. doi: 10.1016/j.ejmech.2012.11.009.", "ArticleIdList": ["10.1016/j.ejmech.2012.11.009", "23220640"]}, {"Citation": "Song W.J., Yang X.D., Zeng X.H., Xu X.L., Zhang G.L., Zhang H.B. Synthesis and Cytotoxic Activities of Novel Hybrid Compounds of Imidazole Scaffold-Based 2-Substituted Benzofurans. RSC Adv. 2012;2:4612\u20134615. doi: 10.1039/c2ra20376f.", "ArticleIdList": ["10.1039/c2ra20376f"]}, {"Citation": "Chen W., Yang X.D., Li Y., Yang L.J., Wang X.Q., Zhang G.L., Zhang H.B. Design, Synthesis and Cytotoxic Activities of Novel Hybrid Compounds between Dihydrobenzofuran and Imidazole. Org. Biomol. Chem. 2011;9:4250\u20134255. doi: 10.1039/c1ob05116d.", "ArticleIdList": ["10.1039/c1ob05116d", "21505704"]}, {"Citation": "Ali I., Lone M.N., Aboul-Enein H.Y. Imidazoles as Potential Anticancer Agents. Medchemcomm. 2017;8:1742\u20131773. doi: 10.1039/C7MD00067G.", "ArticleIdList": ["10.1039/C7MD00067G", "PMC6084102", "30108886"]}, {"Citation": "Berger D.M., Dutia M., Birnberg G., Powell D., Boschelli D.H., Wang Y.D., Ravi M., Yaczko D., Golas J., Lucas J., et al. 4-Anilino-7,8-Dialkoxybenzo[g]Quinoline-3-Carbonitriles as Potent Src Kinase Inhibitors. J. Med. Chem. 2005;48:5909\u20135920. doi: 10.1021/jm050512u.", "ArticleIdList": ["10.1021/jm050512u", "16161995"]}, {"Citation": "Tsao A.S., He D., Saigal B., Liu S., Lee J.J., Bakkannagari S., Ordonez N.G., Waun K.H., Wistuba I., Johnson F.M. Inhibition of C-Src Expression and Activation in Malignant Pleural Mesothelioma Tissues Leads to Apoptosis, Cell Cycle Arrest, and Decreased Migration and Invasion. Mol. Cancer Ther. 2007;6:1962\u20131972. doi: 10.1158/1535-7163.MCT-07-0052.", "ArticleIdList": ["10.1158/1535-7163.MCT-07-0052", "17620427"]}, {"Citation": "Summy J.M., Gallick G.E. Src Family Kinases in Tumor Progression and Metastasis. Cancer Metastasis Rev. 2003;22:337\u2013358. doi: 10.1023/A:1023772912750.", "ArticleIdList": ["10.1023/A:1023772912750", "12884910"]}, {"Citation": "Li M., Zhao B.X. Progress of the Synthesis of Condensed Pyrazole Derivatives (from 2010 to Mid-2013) Eur. J. Med. Chem. 2014;85:311\u2013340. doi: 10.1016/j.ejmech.2014.07.102.", "ArticleIdList": ["10.1016/j.ejmech.2014.07.102", "25104650"]}, {"Citation": "Bennani F.E., Doudach L., Cherrah Y., Ramli Y., Karrouchi K., Ansar M., Faouzi M.E.A. Overview of Recent Developments of Pyrazole Derivatives as an Anticancer Agent in Different Cell Line. Bioorg. Chem. 2020;97 doi: 10.1016/j.bioorg.2019.103470.", "ArticleIdList": ["10.1016/j.bioorg.2019.103470", "32120072"]}, {"Citation": "Patil V.M., Masand N., Verma S., Masand V. Chromones: Privileged Scaffold in Anticancer Drug Discovery. Chem. Biol. Drug Des. 2021;98:943\u2013953. doi: 10.1111/cbdd.13951.", "ArticleIdList": ["10.1111/cbdd.13951", "34519163"]}, {"Citation": "Van Meerloo J., Kaspers G.J.L., Cloos J. Cell Sensitivity Assays: The MTT Assay. Methods Mol. Biol. 2011;731:237\u2013245. doi: 10.1007/978-1-61779-80-5_20.", "ArticleIdList": ["10.1007/978-1-61779-80-5_20", "21516412"]}, {"Citation": "Alsayari A., Muhsinah A.B., Hassan M.Z., Ahsan M.J., Alshehri J.A., Begum N. Aurone: A Biologically Attractive Scaffold as Anticancer Agent. Eur. J. Med. Chem. 2019;166:417\u2013431. doi: 10.1016/j.ejmech.2019.01.078.", "ArticleIdList": ["10.1016/j.ejmech.2019.01.078", "30739824"]}, {"Citation": "Thakur A., Singla R., Jaitak V. Coumarins as Anticancer Agents: A Review on Synthetic Strategies, Mechanism of Action and SAR Studies. Eur. J. Med. Chem. 2015;101:476\u2013495. doi: 10.1016/j.ejmech.2015.07.010.", "ArticleIdList": ["10.1016/j.ejmech.2015.07.010", "26188907"]}, {"Citation": "Boumendjel A. Aurones: A Subclass of Flavones with Promising Biological Potential. Curr. Med. Chem. 2003;10:2621\u20132630. doi: 10.2174/0929867033456468.", "ArticleIdList": ["10.2174/0929867033456468", "14529476"]}, {"Citation": "Kontogiorgis C., Detsi A., Hadjipavlou-Litina D. Coumarin-Based Drugs: A Patent Review (2008-Present) Expert Opin. Ther. Pat. 2012;22:437\u2013454. doi: 10.1517/13543776.2012.678835.", "ArticleIdList": ["10.1517/13543776.2012.678835", "22475457"]}, {"Citation": "Zwergel C., Gaascht F., Valente S., Diederich M., Bagrel D., Kirsch G. Aurones: Interesting Natural and Synthetic Compounds with Emerging Biological Potential. Nat. Prod. Commun. 2012;7:389\u2013394. doi: 10.1177/1934578X1200700322.", "ArticleIdList": ["10.1177/1934578X1200700322", "22545415"]}, {"Citation": "Zhuang C., Zhang W., Sheng C., Zhang W., Xing C., Miao Z. Chalcone: A Privileged Structure in Medicinal Chemistry. Chem. Rev. 2017;117:7762\u20137810. doi: 10.1021/acs.chemrev.7b00020.", "ArticleIdList": ["10.1021/acs.chemrev.7b00020", "PMC6131713", "28488435"]}, {"Citation": "Zhou B., Xing C. Diverse Molecular Targets for Chalcones with Varied Bioactivities. Med. Chem. 2015;5:388\u2013404. doi: 10.4172/2161-0444.1000291.", "ArticleIdList": ["10.4172/2161-0444.1000291", "PMC4718574", "26798565"]}, {"Citation": "Karthikeyan C., Narayana Moorthy N.S.H., Ramasamy S., Vanam U., Manivannan E., Karunagaran D., Trivedi P. Advances in Chalcones with Anticancer Activities. Recent Pat. Anticancer Drug Discov. 2015;10:97\u2013115. doi: 10.2174/1574892809666140819153902.", "ArticleIdList": ["10.2174/1574892809666140819153902", "25138130"]}, {"Citation": "Kumar V., Kaur K. Triazole and Oxadiazole Containing Natural Products: A Review. Nat. Prod. J. 2014;4:115\u2013130. doi: 10.2174/221031550402141009100114.", "ArticleIdList": ["10.2174/221031550402141009100114"]}, {"Citation": "Nayak S., Gaonkar S.L., Musad E.A., Dawsar A.M.A. 1,3,4-Oxadiazole-Containing Hybrids as Potential Anticancer Agents: Recent Developments, Mechanism of Action and Structure-Activity Relationships. J. Saudi Chem. Soc. 2021;25:101284. doi: 10.1016/j.jscs.2021.101284.", "ArticleIdList": ["10.1016/j.jscs.2021.101284"]}, {"Citation": "Xu Z., Zhao S.J., Liu Y. 1,2,3-Triazole-Containing Hybrids as Potential Anticancer Agents: Current Developments, Action Mechanisms and Structure-Activity Relationships. Eur. J. Med. Chem. 2019;183:111700. doi: 10.1016/j.ejmech.2019.111700.", "ArticleIdList": ["10.1016/j.ejmech.2019.111700", "31546197"]}, {"Citation": "Alam M.M. 1,2,3-Triazole Hybrids as Anticancer Agents: A Review. Arch. Pharm. 2022;355:e2100158. doi: 10.1002/ardp.202100158.", "ArticleIdList": ["10.1002/ardp.202100158", "34559414"]}, {"Citation": "Pervaram S., Ashok D., Sarasija M., Reddy C.V.R., Sridhar G. Synthesis and Anticancer Activity of 1,2,4-Oxadiazole Fused Benzofuran Derivatives. Russ. J. Gen. Chem. 2018;88:1219\u20131223. doi: 10.1134/S1070363218060282.", "ArticleIdList": ["10.1134/S1070363218060282"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "15"}, {"Year": "2022", "Month": "4", "Day": "17"}, {"Year": "2022", "Month": "4", "Day": "25"}, {"Year": "2022", "Month": "5", "Day": "14", "Hour": "1", "Minute": "18"}, {"Year": "2022", "Month": "5", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "15", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "4", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["35565325", "PMC9099631", "10.3390/cancers14092196", "cancers14092196"]}}], "PubmedBookArticle": []}